Keyphrases
Fibrin Glue
100%
Resveratrol
75%
Trabeculectomy
56%
Mitomycin C
55%
Transforming Growth Factor-β
53%
Triamcinolone Acetonide
44%
Fibrosis
40%
Bevacizumab
39%
Human Tenon Fibroblast
37%
Open Globe Injury
37%
Limbal Stem Cells
37%
Mesenchymal Stem Cell-derived Exosomes
37%
Type I Collagen
37%
Treatment Group
34%
Matrix metalloproteinase-3 (MMP-3)
32%
Growth Factors
31%
Conjunctival
28%
Rabbit Eye
27%
Intravitreal
27%
Human Pterygium Fibroblasts
25%
Intracameral Injection
25%
Retinal Ganglion Cell Loss
25%
WJ-MSCs
25%
Dry Eye
25%
Injury Model
25%
Ischemia-reperfusion Injury
25%
Curcumin
25%
Wound Healing
24%
Bleb Fibrosis
24%
Inflammation
23%
Vascular Endothelial Growth Factor
23%
Antifibrotic
23%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
22%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
20%
New Zealand White Rabbit
20%
Phacoemulsification
20%
Glaucoma
19%
Platelet-rich Fibrin
18%
Platelet-rich Fibrin Membrane
18%
Extracellular Matrix
18%
Beneficial Effects
18%
Glaucomatous
17%
Stem Cell Secretome
17%
Cell Proliferation
17%
Myofibroblast
16%
MMC
16%
Factor Level
16%
Immunohistochemistry
16%
Epidermal Growth Factor
16%
Intravitreal Ranibizumab
15%
Medicine and Dentistry
Fibrin Glue
75%
Fibrosis
60%
Fibroblast
50%
Trabeculectomy
42%
Mitomycin
42%
Bevacizumab
37%
Triamcinolone Acetonide
37%
Mesenchymal Stem Cell
37%
Transforming Growth Factor Beta
27%
Wound Healing
26%
Resveratrol
25%
Platelet-Rich Fibrin
25%
Pterygium
25%
Curcumin
25%
Asiatic Acid
25%
Strabismus Surgery
25%
Collagen Type 1
24%
Treatment Group
22%
Stromelysin
20%
Antifibrotic Agent
19%
Caspase 3
18%
Intraocular Pressure
17%
Phacoemulsification
16%
Vasculotropin
15%
Extracellular Matrix
15%
Ocular Surface
15%
Eye Disease
15%
Clinical Examination
15%
Downregulation
15%
Interleukin 4
15%
Glaucoma
14%
Immunohistochemistry
14%
In Vitro
13%
Cell Migration
12%
Penetrating Trauma
12%
Corneal Wound Healing
12%
Matrix Metalloproteinase
12%
Corpus Callosum Agenesis
12%
Congenital Glaucoma
12%
Cell Loss
12%
Closed Angle Glaucoma
12%
Wharton Jelly
12%
Dry Eye
12%
Migration Inhibition
12%
Ophthalmology
12%
Ganglion
12%
Amnion
12%
Pseudomonas aeruginosa
12%
Keratitis
12%
Endothelial Cell
12%
Pharmacology, Toxicology and Pharmaceutical Science
Triamcinolone Acetonide
51%
Bevacizumab
38%
Fibrin Glue
37%
Resveratrol
37%
Transforming Growth Factor Beta
37%
Wound Healing
37%
Leporidae
28%
Vasculotropin
25%
Fibrosis
25%
Mitomycin
25%
Reperfusion Injury
25%
Asiatic Acid
25%
Strabismus
25%
Inflammation
23%
Intravitreal Administration
21%
New Zealand Rabbit
16%
Vitreoretinopathy
16%
Neuroprotective Agent
15%
Interleukin 4
15%
Dexamethasone
13%
Eye Disease
13%
Treatment Group
12%
Biomaterial
12%
Collagen Type 1
12%
Platelet-Rich Fibrin
12%
Keratitis
12%
Scatter Factor
12%
Dry Eye
12%
Pterygium
12%
Penetrating Trauma
12%
Cornea Injury
12%
Pseudomonas aeruginosa
12%
Epidermal Growth Factor
12%
Matrix Metalloproteinase
12%
Plasminogen Activator Inhibitor 1
12%
Smooth Muscle Actin
12%
Chemical Injury
12%
Curcumin
12%
Antiapoptotic
12%
Wound
11%
Caspase 3
11%
Gelatinase A
8%
Tissue Inhibitor of Metalloproteinase
8%
Phosphate Buffered Saline
7%
Tumor Necrosis Factor
7%
Growth Factor
6%
Actin
6%
Eye Injury
6%
Glaucoma
5%
Recurrent Disease
5%